🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Tennessee › Nashville

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Nashville, TN

8 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Ap rekriteFaz 2
  • Urology Associates PC, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06995677

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Ap rekriteFaz 1
  • Urology Associates, P.C., Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07206225

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Ap rekriteFaz 2
  • Urology Associates PC, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Ap rekriteFaz 1
  • Sarah Cannon and HCA Research Institute, Nashville
  • Tennessee Oncology, Nashville
  • Vanderbilt University Medical Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Ap rekriteFaz 1/2
  • Urology Associates, P.C., Nashville
  • Vanderbilt Univerity Medical Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Ap rekriteEtid obsèvasyon
  • Vanderbilt University Medical Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07225127

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Ap rekriteFaz 1/2
  • Urology Associates, P.C., Nashville
Laj 18 a 85 · Tout sèks · Mizajou Mar 27, 2026 · NCT06800963

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Ap rekriteFaz 2
  • Site 02-007 - Urology Associates, P. C, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Nov 24, 2025 · NCT03945162

Etid Kansè Vezik ki pa envazif miskilè nan lòt vil

Lòt etid nan Nashville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.